Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/mcp.M200065-MCP200 on October 5, 2002.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M200065-MCP200v1
1/10/805    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krause, C. D.
Right arrow Articles by Pestka, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krause, C. D.
Right arrow Articles by Pestka, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 1:805-815, 2002.
© 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Research

Seeing the Light

Preassembly and Ligand-Induced Changes of the Interferon {gamma} Receptor Complex in Cells*

Christopher D. Krause{ddagger}, Erwen Mei, Junxia Xie{ddagger}, Yiwei Jia§, Martin A. Bopp, Robin M. Hochstrasser and Sidney Pestka{ddagger},||

{ddagger} Department of Molecular Genetics, Microbiology and Immunology, Robert Wood Johnson Medical School-University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey 08854
§ Olympus America Inc., Melville, New York 11747-3157
Regional Laser and Biomedical Technology Laboratories, Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104


   ABSTRACT
TOP
 ABSTRACT
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Our experiments were designed to test the hypothesis that the cell surface interferon {gamma} receptor chains are preassembled rather than associated by ligand and to assess the molecular changes on ligand binding. To accomplish this, we used fluorescence resonance energy transfer, a powerful spectroscopic technique that has been used to determine molecular interactions and distances between the donor and acceptor. However, current commercial instruments do not provide sufficient sensitivity or the full spectra to provide decisive results of interactions between proteins labeled with blue and green fluorescent proteins in living cells. In our experiments, we used the blue fluorescent protein and green fluorescent protein pair, attached a monochrometer and charge-coupled device camera to a modified confocal microscope, reduced background fluorescence with the use of two-photon excitation, and focused on regions of single cells to provide clear spectra of fluorescence resonance energy transfer. In contrast to the prevailing view, the results demonstrate that the receptor chains are preassociated and that the intracellular domains move apart on binding the ligand interferon {gamma}. Application of this technology should lead to new rapid methods for high throughput screening and delineation of the interactome of cells.

Specific protein-protein interactions are fundamental to most cellular functions, yet investigation of protein-protein interactions under physiological conditions has been problematic. Considerable effort has been made to identify these interactions. Typically these interactions have been detected by co-precipitation experiments in which an antibody to a known protein is mixed with a cell extract and used to precipitate the known protein and any proteins that are stably associated with it. However, the method does not yield data in real time in cells. Another approach has been to use an interaction trap system (the yeast two-hybrid system) to identify polypeptide sequences that bind to a predetermined polypeptide sequence present in a fusion protein in cells (1). As originally developed, the yeast two-hybrid system requires that both proteins to be tested be in the nucleus for the transcriptional activation to occur. To overcome this limitation, a method that does not involve transcription was developed to identify proteins that interact in the cytoplasm (2). In general, the two-hybrid method is used to identify novel polypeptide sequences that interact with a known protein (3–10). However, the two-hybrid systems do not permit real-time measurements of the interactions in cells.

Measurement of protein-protein interactions in vivo by non-invasive techniques can help to validate the physiological significance of the interactions and can also aid in identifying changes that occur in a cell or organism in response to physiological stimuli. One way to accomplish this is through fluorescence resonance energy transfer (FRET).1 FRET is a powerful spectroscopic technique that has been used to determine protein-protein interactions and distances between two proteins in complexes (11, 12). In one example, we previously used FRET and fluorescence lifetime measurements to determine the distance between two regions of the ribosome (13). Very little is known about the physical association of specific receptor chains of multichain complexes and whether chains from one receptor type directly interact with another (14). Important answers should be provided by applying the FRET technique to cells.

FRET has begun to be used to determine interactions of proteins on the surface of cells. Monoclonal antibodies to cell surface receptors or other protein were labeled chemically with fluorescein isothiocyanate and Cy3 dyes. The in vitro fluorescent-labeled monoclonal antibodies directed against cell surface receptors were able to measure changes in the distance of the receptor components as a function of ligand concentrations (15–18). The cloning of green fluorescent protein (GFP) has allowed biologists to label proteins with the fluorescent GFP using genetic engineering (19, 20). The pituitary transcription factor (Pit-1) fused to BFP (BFP-Pit-1) was confirmed to interact with the protein c-Est-1 fused to GFP (GFP-Ets-1) by FRET, an association that was previously shown by co-immunoprecipitation (21). The association of Bcl-2 and Beclin fused to various mutants of GFP was determined by FRET (22). Additional reports in the last few years have begun to determine the association of proteins in cells with the use of GFP and BFP or cyan fluorescent protein and yellow fluorescent protein pairs (23–35). The use of fluorescence lifetime imaging microscopy can eliminate the need for spectral separation and problems in FRET (36) as we found previously by pure spectral methods (13) because fluorescence lifetime measurements permit calculation of distances between donor and acceptor fluorophores totally independent of FRET (11, 12). Another technique, fluorescence recovery after photobleaching, was used to demonstrate the interaction of Ras and Rap1 in cells (37). In our experiments, we used the BFP and GFP pair, attached a monochrometer and charge-coupled device camera to a modified confocal microscope, reduced background fluorescence with the use of two-photon excitation, and focused on regions of single cells to provide fluorescence spectra of selected regions that exhibit clear signatures of fluorescence energy transfer. Our experiments were applied to the interferon {gamma} (IFN-{gamma}) receptor complex to test the hypothesis that the receptor chains are preassociated and to assess the molecular changes on ligand binding.

Interferons initiate signal transduction through specific cell surface receptors (14, 38–40). IFN-{gamma} binds to the IFN-{gamma} receptor binding subunit (IFN-{gamma}R1; receptor chain 1), a species-specific cell surface transmembrane receptor chain (41, 42). A second transmembrane protein (IFN-{gamma}R2) (43–45) is required for signal transduction (Fig. 1). The overall objective of our efforts is to provide an improved method to detect protein-protein interactions under physiological conditions in live cells by using FRET and to determine effects of ligands and other agents on the interactions by examining the IFN-{gamma} receptor complex in detail by FRET.



View larger version (29K):
[in this window]
[in a new window]
  		FIG. 1. Traditional model of the IFN-{gamma} receptor complex. The IFN-{gamma} receptor complex consists of two different chains, IFN-{gamma}R1 and IFN-{gamma}R2 (14, 42, 44, 45, 82, 91, 93–95). The ligand IFN-{gamma} is a dimer that binds to two IFN-{gamma}R1 chains but does not directly bind to the IFN-{gamma}R2 chain in the absence of the IFN-{gamma}R1 chain. In the current model, upon IFN-{gamma}R1 binding, the receptor chains associate to form a condensed complex that activates the Jak kinases that cross-phosphorylate each other (solid circles). The activated Jak kinases then phosphorylate tyrosine 457 of each IFN-{gamma}R1 chain that serves as the recruitment site for Stat1{alpha}, which in turn is phosphorylated by the Jak kinases. Once phosphorylated, the phosphorylated Stat1{alpha} proteins detach from each IFN-{gamma}R1 chain and then dimerize to form the transcription factor that is translocated to the nucleus to activate IFN-{gamma}-regulated genes.

 
Although a great deal of information has accumulated about cell surface receptors from biochemical observations, no direct measurements of receptor structure have been made in cells in the presence and absence of ligand. In most cases, the models of multichain receptor complexes were deduced from a combination of cross-linking, immunoprecipitation of the constituent proteins, and delineation of the signal transduction events. For example, based on a wide variety of studies the commonly held opinion has been that ligands join surface receptor chains that are not associated prior to attachment of ligand (46–53). All these results were deduced from indirect measurements. However, some more recent observations have begun to suggest that receptor chains can be preassociated in the cell membrane (54–80). To provide a direct way to clarify the various models of receptor action, we established an approach to measure interactions of receptor chains in living cells. To assess the structure of the receptor chains and the effects of ligands directly, we used FRET and focused on the IFN-{gamma} receptor. The chains and functions of the IFN-{gamma} receptor complex have been defined in some detail over the past 2 decades (14, 39, 81–83). Indirect evidence exists about the structure of the IFN-{gamma} receptor complex prior to its activation by IFN-{gamma}. Most investigators have concluded that the IFN-{gamma} receptor and other receptors are assembled after ligand binding because only then was optimal immunoprecipitation of both chains obtained with an antibody to IFN-{gamma}R1 (84–86). Accordingly, most models of the IFN-{gamma} receptor consider it to consist of four chains: two IFN-{gamma}R1 and two IFN-{gamma}R2 chains, consistent with a large body of data. The ligand IFN-{gamma} is a dimer that binds to two IFN-{gamma}R1 chains but does not directly bind to the IFN-{gamma}R2 chain in the absence of the IFN-{gamma}R1 chain. In the current model (Fig. 1), upon IFN-{gamma}R1 binding, the receptor chains associate to form a condensed complex that activates the Jak kinases that cross-phosphorylate each other. After binding of ligand, it was concluded that the chains of the IFN-{gamma} receptor complex are brought together, and signal transduction is initiated by ligand binding (Fig. 1). Here we report the results of FRET in examining receptor structure directly and provide evidence for a new model of receptor structure and function.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Construction of Vectors to Measure FRET in Cells and Transfections—
As noted above, GFP and BFP were discovered and developed by a number of groups (19, 20) who enabled these fluorescent proteins to be seen and localized in cells (19–35), and several groups have begun to use FRET to study the interactions of proteins in cells (21–35). In our studies, the IFN-{gamma} receptor complex (Fig. 1) was used as the model system to evaluate the ability of FRET to provide insight into the structure of the receptor and to determine the molecular dynamics after attachment of the ligand IFN-{gamma} to the receptor. To carry out these studies, IFN-{gamma}R1 and IFN-{gamma}R2 chains with EBFP (enhanced BFP cDNA optimized to contain mammalian codons) and GFP fused to the carboxyl termini of their intracellular domains were constructed (Fig. 2, top). EBFP, rather than BFP, was used for all constructions. By fusing the DNA encoding the EBFP to the DNA encoding the carboxyl terminus of the IFN-{gamma}R1 chain and by fusing the DNA encoding GFP to the DNA encoding the carboxyl terminus of the IFN-{gamma}R2 chain, the cells produce IFN-{gamma}R1/EBFP and IFN-{gamma}R2/GFP when these recombinant expression vectors are transfected into cells. In this way, the EBFP and GFP were fused to the intracellular domains of IFN-{gamma}R1 and IFN-{gamma}R2, respectively (Fig. 2) to monitor interactions among these two receptor chains in intact cells with and without IFN-{gamma} treatment. All IFN-{gamma}R2 constructions contained the FLAG (FL) epitope as noted in the figure legends. The detailed construction of FL-IFN-{gamma}R2/{gamma}R2 (first {gamma}R2 represents extracellular domain and second {gamma}R2 represents intracellular domain) was described in detail elsewhere (87, 88). It differs from the wild type IFN-{gamma}R2 sequence in the following ways: the FLAG epitope was placed between the end of the putative signal peptide sequence and the putative beginning of the extracellular domain, and an NheI site was engineered into the beginning of the transmembrane domain, producing a three-amino acid mutation. Neither change affected the function of IFN-{gamma}R2. Because it was necessary to have cells express two proteins labeled with EBFP and GFP at similar levels, we used a single vector expressing both proteins for transfection rather than co-transfection with two vectors. Thus, tandem vectors, in which transcription of each cDNA is controlled by its own separate promoter and polyadenylation signal on a single plasmid, were constructed as described previously (88). The plasmid harboring the IFN-{gamma}R1 chain (or the IL-10R1 chain) was digested at the 3' end with MluI and at the 5' end with BglII. The large fragment, encoding the IFN-{gamma}R1 cDNA and its expression elements, was retained. The plasmid harboring the FL-IFN-{gamma}R2 chain (or the FL-IL-10R2 chain) was digested with BglII at its 5' end and BssHII at its 3' end. The larger fragment, retaining the FL-IFN-{gamma}R2 cDNA and its expression elements, was retained. Ligation of the cohesive ends yielded tandem vectors. To prepare EBFP or GFP fusion products, the segments encoding EBFP or GFP were amplified by PCR from appropriate vectors (89, 90) and then fused to the vectors expressing FL-IFN-{gamma}R2, IFN-{gamma}R1, or IL-10R2 with EBFP or GFP attached to the 3' terminus of the expression construct to make FL-IFN-{gamma}R2/EBFP, FL-IFN-{gamma}R2/GFP, IFN-{gamma}R1/EBFP, and IL-10R2/GFP, respectively. Schematic illustrations of the resultant EBFP- and GFP-labeled receptor chains are shown in Figs. 2 and 3. Transient transfections in COS-1 cells by the DEAE-dextran protocol (91) were used for all experiments except where noted. Stable transformants were made in the Chinese hamster ovary (CHO)-derived cell line q3 by the Lipofectin method and limiting dilution clonal isolation. The derivation of the CHO q3 cell line is described in the legend to Fig. 3.



View larger version (16K):
[in this window]
[in a new window]
  		FIG. 2. Schematic of fluorescence transfer between blue and green fluorescent proteins fused to IFN-{gamma}R1 and IFN-{gamma}R2 chains. EBFP and GFP were fused to the IFN-{gamma}R1 and IFN-{gamma}R2 chains shown in the upper portion of the figure and described under "Experimental Procedures." Because the cellular background was high when the EBFP was excited with blue light at 380 nm, infrared light at 760 nm was used to excite the EBFP with two photons. With no fluorescence transfer, the excitation of the EBFP will emit light with a maximum at 445 nm. If fluorescence transfer from EBFP to GFP occurs, the maximum wavelength of the emitted light will be seen at 509 nm.

 


View larger version (30K):
[in this window]
[in a new window]
  		FIG. 3. Fluorescent receptor chains are functional. The human receptor chains (IFN-{gamma}R1 and FL-IFN-{gamma}R2) without fluorescent proteins (left panel) and those with the fluorescent proteins (IFN-{gamma}R1/EBFP and FL-IFN-{gamma}R2/GFP) (right panel) were transfected into CHO q3 cells, and MHC Class I antigen induction was measured in response to hamster and human IFN-{gamma}. In the absence of the human receptor chains, Hu-IFN-{gamma} has no effect on CHO cells (82, 91, 102). The hamster IFN-{gamma} was used as a positive control to show that the CHO cells can propagate IFN-{gamma} signaling. The CHO q3 cells were derived as follows. Hamster UCH-12 cells containing a stable translocation of human chromosome 3q were obtained from Carol Jones and David Patterson. UCH-12 cells were transfected with plasmid pJY150R1.1 that encodes the intact HLAB7 gene (104), and the resulting cells were designated q3. This hamster cell line, derived from CHO-K1, does not express Hu-IFN-{gamma}R1 or Hu-IFN-{gamma}R2 and can reconstitute signaling in response to Hu-IFN-{gamma} only when both chains are expressed in these cells. The stably transfected population of q3 cells was grown in F12 medium supplemented with 10% fetal bovine serum without selecting antibiotics. Selection was performed by sorting of 2% of cells exhibiting the greatest fluorescence in an MHC Class I assay after 3 days of treatment with Hu-IFN-ß. After three rounds of selection, individual clones were isolated by limiting dilution and amplified. Clones were isolated that induced significantly higher levels of MHC Class I surface antigen in response to hamster IFN-{gamma}. From these clones, one clone (designated q3) was chosen that possessed a high efficiency of transfection with a plasmid encoding Hu-IFN-{gamma}R1 and Hu-IFN-{gamma}R2 and exhibited expression of reconstituted human IFN-{gamma} receptor complexes assayed by MHC Class I surface antigen induction of the geneticin-resistant transfected population in response to Hu-IFN-{gamma}. MHC Class I antigen induction in response to IFN-{gamma} was performed as described previously (82). Ham, hamster.

 
Analysis of FRET between Receptor Chains in Single Cells: FRET and Equipment Used—
To demonstrate GFP and EBFP fluorescence and FRET, a confocal microscope was modified to include a monochrometer associated with a back illumination liquid nitrogen-cooled charge-coupled device camera so that fluorescence emission spectra could be obtained from illuminated cells. The S65T variant of GFP with an excitation maximum at 488 nm was used in all our studies (92). The enhanced GFP (EGFP) optimized for mammalian codons has the same excitation and emission maxima as GFP (S65T), 488 and 509 nm, respectively. We used GFP rather than EGFP in these experiments because EGFP was not available at the time we began the constructions. Single-photon excitation at 488 nm of the GFP with an argon laser delivering 0.5 microwatt at the sample yielded the signature GFP emission having a maximum at 509 nm. The BFP and EBFP have excitation and emission maxima at 380 nm and 445 nm, respectively. Because we found that excitation at 380 of cells produced very high background fluorescence, we used two-photon excitation to substantially reduce the sample excitation volume along with quartz cover slides, which resulted in a significantly decreased background fluorescence. The infrared light produced little or no cellular damage compared with ultraviolet light. To excite the EBFP at its excitation maximum of 380 nm, a pulsed femtosecond mode-locked infrared Ti:sapphire laser (2 milliwatts) was tuned to 760 nm. As illustrated in the lower part of Fig. 2, two-photon excitation (760 nm) of EBFP effectively excites the protein at it is maximum absorption at 380 nm to produce an emission spectrum with a maximum at 445 nm. If FRET occurs between EBFP and GFP, then the emission maximum of GFP at 509 nm will be observed.

Images, Spectra, and Activity of Human IFN-{gamma}R2/GFP and IFN-{gamma}R1/EBFP Transfected into Cells—
The constructs expressing IFN-{gamma}R2/GFP and IFN-{gamma}R2/EBFP were individually transfected into COS-1 cells, and images were taken with a camera attached to a confocal microscope. The images show that both IFN-{gamma}R2/GFP (Fig. 4, top left) and IFN-{gamma}R2/EBFP (Fig. 4, top right) were visualized by epifluorescence after transfection upon exciting the IFN-{gamma}R2/GFP at 488 and the IFN-{gamma}R2/EBFP at 380 nm. Similar images were obtained for IFN-{gamma}R1/EBFP (not shown). To demonstrate that each of the constructs was functional, vectors expressing IFN-{gamma}R2/GFP or IFN-{gamma}R1/EBFP were transfected into CHO cells expressing the complementary human chain (44, 82, 91). MHC Class I induction by IFN-{gamma} demonstrated that each chain was functional (data not shown). To demonstrate that the constructs were functional when transfected together into cells, a tandem vector coexpressing IFN-{gamma}R2/GFP and IFN-{gamma}R1/EBFP was transfected into Chinese hamster ovary cells expressing none of the human IFN-{gamma} receptor chains (CHO q3). The MHC Class I surface antigen induction in response to IFN-{gamma} in CHO q3 cells expressing IFN-{gamma}R2/GFP and IFN-{gamma}R1/EBFP (Fig. 3, right panels) shows that both receptor chains are functional. Similar activity measurements with other receptor chains such as IFN-{gamma}R2/EGFP, IFN-{gamma}R2/EBFP, and FL-IL-10R2/GFP demonstrated that all these receptor chains with fluorescent proteins fused to their carboxyl termini were functional.



View larger version (31K):
[in this window]
[in a new window]
  		FIG. 4. The fluorescent receptor chains exhibit their characteristic fluorescent signatures: images and spectra of human IFN-{gamma}R2/GFP and IFN-{gamma}R2/EBFP transfected into cells. FL-IFN-{gamma}R2/GFP and FL-IFN-{gamma}R2/EBFP were each separately transfected into COS cells. A camera was used with the confocal microscope to obtain the images for human IFN-{gamma}R2/GFP (top left) and IFN-{gamma}R2/EBFP (top right) in COS-1 cells. Similar images were obtained for IFN-{gamma}R1/BFP and IFN-{gamma}R1/EBFP (not shown). The spectral signatures of GFP (green) and EBFP (blue) can be seen in COS-1 cells expressing FL-IFN-{gamma}R2/GFP and FL-IFN-{gamma}R2/EBFP (lower left and right, respectively). The black curves represent the relative epifluorescence of the cells in the absence of the respective transfected fluorescent receptor chains.

 

   RESULTS
TOP
 ABSTRACT
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
The carboxyl-terminal end of the intracellular domain of the two chains of the human IFN-{gamma} receptor complex, Hu-IFN-{gamma}R1 and Hu-IFN-{gamma}R2, were fused to EBFP and GFP, respectively (Fig. 2). In addition, the carboxyl-terminal end of the intracellular domain of the IL-10R2 chain was fused to GFP as a control. To ascertain that the receptor chains with GFP and EBFP (Fig. 3, right panel) were functional, these chains were transfected into CHO q3 cells to determine whether they could function as well as the same chains without the fluorescent proteins (Fig. 3, left panel). The results show that MHC Class I antigen induction in response to human IFN-{gamma} was as effective as that of hamster IFN-{gamma}, demonstrating that the receptor chains with or without GFP and EBFP were functional. Cells were transfected with the IFN-{gamma}R2/EBFP and IFN-{gamma}R2/GFP separately to establish that the chains fused to EBFP and GFP, respectively, provided the expected fluorescence signatures. The spectral signature of GFP and EBFP was seen in cells expressing IFN-{gamma}R2/GFP (Fig. 4, left panels; excited at 488 nm) and IFN-{gamma}R2/EBFP (Fig. 4, right panels; excited at 380 nm). Identical spectral signatures were observed in cells expressing IFN-{gamma}R1/EBFP and IFN-{gamma}R2/BFP (data not shown). Thus the data showed that both IFN-{gamma}R2/EBFP and IFN-{gamma}R2/GFP provided the expected spectral signatures (Fig. 4). However, there was substantial background fluorescence when EBFP was excited at 380 nm so that we used two-photon excitation (760 nm) to minimize this in the subsequent FRET assays.

We next prepared transient transfectants in COS-1 cells expressing matched (Hu-IFN-{gamma}R1 and Hu-IFN-{gamma}R2) and mismatched (Hu-IFN-{gamma}R1 and Hu-IL-10R2) receptor pairs (Fig. 5). The matched pair, Hu-IFN-{gamma}R1/EBFP and Hu-IFN-{gamma}R2/GFP, represents the two chains of the Hu-IFN-{gamma} receptor complex. The mismatched pair represents two chains from similar receptor complexes, Hu-IFN-{gamma}R1/EBFP and Hu-IL-10R2/GFP, but are not known to interact. FRET was measured upon excitation at 760 nm in cells expressing each of these pairs of receptor chains in the absence of ligand (Fig. 6). The spectrum of cells expressing the mismatched pair Hu-IFN-{gamma}R1/EBFP and Hu-IL-10R2/GFP shows the blue (EBFP) spectrum together with background fluorescence, demonstrating little or no interaction of these receptor chains. In contrast, the matched pair, Hu-IFN-{gamma}R1/EBFP and Hu-IFN-{gamma}R2/GFP, excited at 760 nm exhibits the fluorescence emission signature of the GFP, demonstrating clear transfer between the EBFP and GFP proteins. The distance between the intracellular regions of IFN-{gamma}R1/EBFP and IFN-{gamma}R2/GFP chains was calculated (13) to be 36 Å, whereas the distance between the Hu-IFN-{gamma}R1/EBFP and Hu-IL-10R2/GFP was not measurable.2 Thus, the IFN-{gamma}R1 and IFN-{gamma}R2 chains are preassociated prior to ligand binding as demonstrated by the significant FRET and the GFP signature with maximum of about 509 nm on excitation at 760 nm. Addition of the ligand IFN-{gamma} to cells expressing the mismatched pair IFN-{gamma}R1/EBFP and IL-10R2/GFP did not affect the spectrum (Fig. 7). The spectra were virtually identical in the presence or absence of IFN-{gamma}. In contrast, the effect of IFN-{gamma} on the FRET of the matched receptor pair expressed in cells showed that IFN-{gamma} produced a change in the spectrum, causing a major reduction in the FRET compared with the FRET in the absence of IFN-{gamma} (Fig. 8). The distance between the intracellular regions of Hu-IFN-{gamma}R1/EBFP and Hu-IFN-{gamma}R2/GFP chains in the absence and presence of ligand was calculated (13) to be 36 and 63 Å, respectively. Therefore, the intracellular domains of the IFN-{gamma}R1/EBFP and IFN-{gamma}R2/GFP chains move apart on addition of ligand.



View larger version (20K):
[in this window]
[in a new window]
  		FIG. 5. Illustration of matched (FL-IFN-{gamma}R2/GFP and IFN-{gamma}R1/EBFP) and mismatched (IFN-{gamma}R1/EBFP and FL-IL-10R2/GFP) pairs of receptors. The matched pair, FL-IFN-{gamma}R2/GFP and FL-IFN-{gamma}R1/EBFP, are the two chains of the IFN-{gamma} receptor complex fused to GFP and EBFP, respectively. The mismatched pair, IFN-{gamma}R1/EBFP and FL-IL-10R2/GFP, are the first chain of the IFN-{gamma} receptor complex and the second chain of the IL-10 receptor complex, fused to EBFP and GFP, respectively.

 


View larger version (21K):
[in this window]
[in a new window]
  		FIG. 6. Comparison of fluorescence emission spectra of cells expressing the matched and mismatched pair of receptor chains. The matched receptor chains are FL-IFN-{gamma}R2/GFP and IFN-{gamma}R1/EBFP (green curve); the mismatched receptor chains are IFN-{gamma}R1/EBFP and FL-IL-10R2/GFP (blue curve). The fluorescence emission spectra in response to two-photon excitation at 760 nm are shown.

 


View larger version (17K):
[in this window]
[in a new window]
  		FIG. 7. Comparison of fluorescence spectra of cells expressing the mismatched pair of receptor chains in the presence and absence of IFN-{gamma}. The mismatched receptor chains are IFN-{gamma}R1/EBFP and FL-IL-10R2/GFP. The spectrum in red was taken in the absence of IFN-{gamma}. IFN-{gamma} was then added to the medium, and the spectrum was taken (blue curve) of the same region in the same cell. The fluorescence emission spectra in response to two-photon excitation at 760 nm are shown.

 


View larger version (16K):
[in this window]
[in a new window]
  		FIG. 8. Comparison of fluorescence spectra of cells expressing the matched pair of receptor chains in the presence and absence of IFN-{gamma}. The matched receptor chains are FL-IFN-{gamma}R2/GFP and IFN-{gamma}R1/EBFP. The spectrum in green was taken in the absence of IFN-{gamma}. IFN-{gamma} (3500 units/ml) was then added to the medium, and the spectrum was taken (blue curve) of the same region in the same cell. The fluorescence emission spectra in response to two-photon excitation at 760 nm are shown.

 
Because the IFN-{gamma} receptor complex consists of four chains, we examined the effect of ligand on cells expressing only the IFN-{gamma}R2 chain (IFN-{gamma}R2/EBFP and IFN-{gamma}R2/GFP), but no IFN-{gamma}R1 chain, in the presence and absence of ligand (Fig. 9, left panels). In the absence of ligand, FRET was demonstrated between these two IFN-{gamma}R2 chains. There was no change in the spectrum in the presence of IFN-{gamma}. This demonstrated that the IFN-{gamma}R2 chains are preassociated even in the absence of the IFN-{gamma}R1 chains. Furthermore, this observation that IFN-{gamma} did not alter the spectrum and, therefore, the distance between the IFN-{gamma}R2 chains is consistent with previous experiments that showed that IFN-{gamma} did not produce any measurable signal transduction in cells expressing only the IFN-{gamma}R2 chain (44, 45, 82, 91, 93, 94). When the spectra were measured in cells expressing both IFN-{gamma}R2/EBFP and IFN-{gamma}R2/GFP chains together with the IFN-{gamma}R1 chain without a fluorescent tag (Fig. 9, right panels), it was apparent that addition of the ligand IFN-{gamma} changed the spectrum. In the absence of ligand, the spectrum was qualitatively similar in cells expressing IFN-{gamma}R2/EBFP and IFN-{gamma}R2/GFP whether the IFN-{gamma}R1 chain was present or not (Fig. 9, cf. left and right panels). However, in the presence of IFN-{gamma} there was a large change in the spectrum of cells expressing IFN-{gamma}R2/EBFP, IFN-{gamma}R2/GFP, and IFN-{gamma}R1 chains (Fig. 9, right panel). The results demonstrate that the IFN-{gamma}R2 chains are preassociated independently of the presence of the IFN-{gamma}R1 chain but that the IFN-{gamma}R1 chain is required for the IFN-{gamma}R2 chains to move apart in response to IFN-{gamma}. This result is consistent with previous reports that demonstrated that both chains are required for signal transduction (14, 42, 44, 45, 82, 91, 93–95). However, it appears that in the presence of the IFN-{gamma}R1 chain, the IFN-{gamma}R2/EBFP and IFN-{gamma}R2/GFP chains are somewhat closer because there is an increase in FRET in the presence of the IFN-{gamma}R1 chain (Fig. 9, cf. left and right panels).



View larger version (22K):
[in this window]
[in a new window]
  		FIG. 9. Comparison of fluorescence spectra of cells expressing the FL-IFN-{gamma}R2/EBFP and FL-IFN-{gamma}R2/GFP chains in the presence and absence of the IFN-{gamma}R1 chain and in the presence and absence of ligand. COS-1 cells were transfected with FL-IFN-{gamma}R2/EBFP and FL-IFN-{gamma}R2/GFP without transfection with IFN-{gamma}R1 (left panels). COS-1 cells were also transfected with IFN-{gamma}R2/EBFP and IFN-{gamma}R2/GFP together with the IFN-{gamma}R1 chain (right panels). The spectra of the COS-1 cells transfected with the FL-IFN-{gamma}R2/EBFP and FL-IFN-{gamma}R2/GFP in the presence and absence of IFN-{gamma} and in the presence and absence of the IFN-{gamma}R1 chain are shown in the panels. In all experiments with FRET, measurements were taken at 15 min after addition of IFN-{gamma} when noted. All laser excitation experiments were performed with single cells, although multiple cells were sampled and provided similar results. The fluorescence emission spectra in response to two-photon excitation at 760 nm are shown.

 
A model of the IFN-{gamma} receptor complex that is consistent with the data is shown in Fig. 10. In the absence of ligand (Fig. 10, left panel), the intracellular domains of the receptor chains are close to one another, preventing signal transduction as the intracellular components necessary for signaling are prevented from entering the receptor complex by the close proximity of the intracellular domains of these chains. Upon binding of the ligand IFN-{gamma}, the intracellular domains of the receptor chains move apart, opening the area for multiple molecules required for signal transduction to enter the receptor complex (Fig. 10, right panel).



View larger version (20K):
[in this window]
[in a new window]
  		FIG. 10. Model of the change in receptor structure on engagement of the ligand IFN-{gamma}. When IFN-{gamma} binds to the receptor complex, the distance between the IFN-{gamma}R1 and IFN-{gamma}R2 chains and the distance between the two IFN-{gamma}R2 chains increases. Opening the intracellular domain regions provides an opportunity for entry of components of the downstream signal transduction components. The distances and the changes in distances shown are not proportional to the actual measurements.

 

   DISCUSSION
TOP
 ABSTRACT
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
Attempts have been made to assess interactions among the receptor chains by indirect methods; however, except for cross-linking, each method was dependent upon relatively high affinity associations after disruption of the cell. Standard procedures such as immunoprecipitation, cross-linking, size-exclusion chromatography, analytical ultracentrifugation, and laser light scattering were used to investigate the interaction between the two IFN-{gamma}R1 chains and immunoprecipitation and cross-linking between the IFN-{gamma}R1 and IFN-{gamma}R2 chains before and after addition of IFN-{gamma}. Soluble IFN-{gamma}R1 and cell surface membrane-bound IFN-{gamma}R1 was not observed to dimerize in the absence of IFN-{gamma} (86, 96–100). However, it was reported that IFN-{gamma}R1 and IFN-{gamma}R2 chains co-precipitated with antibodies against the IFN-{gamma}R2 before and after addition of IFN-{gamma} (101). In those experiments digitonin, which does not disrupt detergent-resistant micelles, was used to disrupt cellular membranes during the immunoprecipitation procedures, leaving open the possibility that proteins associated with the detergent-resistant micelles could be co-precipitated nonspecifically. In fact, it was later confirmed that disruption of cells with digitonin yielded co-immunoprecipitation of IFN-{gamma}R1 and IFN-{gamma}R2 chains, but the authors noted that use of the ionic detergent Brij-96, which disrupts detergent-resistant micelles, avoided nonspecific co-immunoprecipitations and, at the same time, disrupted the interaction between IFN-{gamma}R1 and IFN-{gamma}R2 chains prior to addition of IFN-{gamma} (84). They and others (84, 86), who used ionic detergents to disrupt cells, concluded that the IFN-{gamma}R1 and IFN-{gamma}R2 chains are not preassociated in the cell membrane prior to addition of the ligand IFN-{gamma} on the basis that co-precipitation of these chains occurred only after IFN-{gamma} was present, results that led to the current accepted model shown in Fig. 1 that indicates that the receptor chains do not associate until the ligand is present. The techniques used to measure protein-protein interactions often remove the proteins from the context of the superstructure of the membranes and other cellular components of which they are an integral part. Thus, high affinity interactions, but not low affinity interactions, can be measured by these procedures. In contrast, the use of FRET permits the direct visualization of all these interactions in cells. Association constants that are too weak to be observed in solution after disruption of cells can be clearly seen by FRET (Figs. 6, 8, and 9) because the receptors are anchored in the membrane.

The effective association constant in solution of two molecules each with two distinct binding sites for association is the product of the association constants for each site times 55, the molarity of water, assuming no conformational constraints. Thus, two low affinity sites can produce an overall high association constant for the molecules. The fact that both receptor chains are anchored in the membrane provides a high affinity site for each, also keeping them at an effective high concentration in the plasma membrane. Furthermore, quantitative measurement of the distances between the fluorescent chains measured helps to avoid artifacts and eliminate nonspecific interactions because only distances less than 100 Å can be observed by FRET with current technology. Thus, when anchored, binding of proteins with relatively low affinity in solution can be visualized clearly by a real-time technique that can measure FRET in live cells. Accordingly, we believe the association of the IFN-{gamma}R1 and IFN-{gamma}R2 chains and other receptor chain pairs has often been missed by the usual assays that measure these interactions after they have been removed from the membrane. This is likely due to the fact that the binding constants of the interactions of the extracellular and/or intracellular domains are probably very low. However, once the receptors are anchored in the membrane, weak interactions take place because the association constant of the two chains in the membrane is a function of the product of the association constant of the membrane binding component and the receptor chain component. Once dissociated from the membrane, the receptor chains have little or no affinity for each other in the absence of ligand. This decrease in entropy of the anchored system increases the likelihood of interactions on the membrane and allows even weak interactions to occur. This phenomenon is used to explain the use of solid surfaces as catalysts in chemical reactions as well as increased avidity of polyvalent compounds for their targets compared with monovalent compounds. These results have ramifications for all proteins and other components of cells. Indeed, we predict this technology will permit the definition of the interactions of many proteins in living cells in real time. Proteins that require additional components to interact in cells will be able to be discerned even though the soluble purified proteins do not appear to associate.

The results demonstrate directly that the receptor chains of the IFN-{gamma} receptor complex are preassembled on the cell membrane. Furthermore, the data prove that the receptor complex consists of four (or possibly more chains) because both the IFN-{gamma}R1 and IFN-{gamma}R2 pair (Figs. 6 and 8) and the IFN-{gamma}R2 and IFN-{gamma}R2 pair (Fig. 9) are preassociated. It is also evident from the data that the IFN-{gamma}R2 and IFN-{gamma}R2 chains are preassociated in the absence of the IFN-{gamma}R1 chain but that the presence of the IFN-{gamma}R1 brings the IFN-{gamma}R2 and IFN-{gamma}R2 chains closer together (Fig. 9). IFN-{gamma} has no effect on the separation of IFN-{gamma}R2 chains in the absence of the IFN-{gamma}R1 chain (Fig. 9, left panel) in accord with previous reports that IFN-{gamma} does not bind to the IFN-{gamma}R2 chain and that IFN-{gamma} exhibits no activity in the presence of the IFN-{gamma}R2 chain only (42, 44, 82, 91, 93, 102, 103). We suggest that this paradigm is likely to be applicable to other receptor chains and that receptor chains are preassociated in cells ready for activation by ligand. This conclusion leads to the deduction that cell surface receptor chains have specific sites, receptor association regions, that enable them to associate. Moreover, the increase in distance between the intracellular regions of the receptor chains opens the receptor complexes for the attachment of the signal transduction components that are excluded from the receptor complexes until ligand engagement. Thus, our direct measurements of the distances between the IFN-{gamma} receptor chains before and after engagement of ligand suggest a new paradigm for receptor structure and function.

Because FRET is a real-time technique, changes in protein-protein interactions or protein positions in complexes in live cells can be determined over the course of time or modulation of the system being analyzed. Because relatively little is known about the physical association of specific receptor chains of multichain complexes and whether chains from one receptor type directly interact with those from another type (14), the use of FRET to determine this should provide an answer to these questions by applying the technique to cells. Furthermore, such studies can be extended to the downstream signal transduction events in response to ligand by determining the order, interactions, and kinetics of these processes. This information will permit the development of pharmaceuticals that can interfere with IFN-{gamma} signaling by interfering with IFN-{gamma} binding to the complex, by blocking the activation of the ligand-receptor complex, or by altering downstream signal transduction events. The protein pairs used in the FRET assays would be adjusted accordingly to measure these specific events. In addition, this technology can be adapted to screen small molecule drugs by a quantitative, sensitive, and rapid real-time assay. A major goal will be to use this technology to study the interaction of receptor chains and of many other proteins in cells under physiological conditions. Ultimately, this strategy could permit delineation of the entire proteome map of any cell, the interactome.

The ability to accomplish this efficiently will have major ramifications for analyzing protein-protein interactions, ligand-receptor interactions, signal transduction, and many other cellular processes. Furthermore, questions relevant to protein interactions in cells that have been addressed indirectly should be able to be answered definitively with direct measurements and the time course of the events determined. The overall objective of our efforts is to provide an improved method to detect protein-protein interactions under physiological conditions in live cells by using FRET and to determine effects of ligands and other agents on the interactions by examining the IFN-{gamma} receptor complex in detail by FRET. The results will have many useful applications in understanding receptor structure and will provide a basis for high throughput screening of receptor ligands in single living cells.


   ACKNOWLEDGMENTS
 
We thank Ellen Feibel and Eleanor Kells for assistance with the preparation of this manuscript. We thank Ralph A. Bradshaw for sharing reference searches and comments, Roger Tsien for the cDNAs encoding GFP variants, Carol Jones and David Patterson for the hamster UCH-12 cells, and Dolph Hatfield for many comments and suggestions to improve the text.


   FOOTNOTES
 
Received, September 29, 2002, and in revised form, October 5, 2002.

Published, MCP Papers in Press, October 5, 2002, DOI 10.1074/mcp.M200065-MCP200

1 The abbreviations used are: FRET, fluorescence resonance energy transfer; CHO, Chinese hamster ovary; EBFP, enhanced blue fluorescent protein; EGFP, enhanced green fluorescent protein; FL, FLAG epitope; GFP, green fluorescent protein; BFP, blue fluorescent protein; IFN-{gamma}, interferon {gamma}; IFN-{gamma}R1, interferon {gamma} receptor chain 1 (also noted as IFN-{gamma}R{alpha} chain); IFN-{gamma}R2, interferon {gamma} receptor chain 2 (also noted as IFN-{gamma}Rß chain); IL-10, interleukin 10; IL-10R1, interleukin 10 receptor chain 1; IL-10R2, interleukin 10 receptor chain 2; HLAB7, human leukocyte antigen B7; Hu, human; MHC, major histocompatibility complex. Back

2 These distances are values of R obtained from R = R0 (IDfA/IA)1/6 where ID and IA are the observed BFP and GFP fluorescence signals, fA is the GFP fluorescence yield, and R0 is the Forster radius for the GFP/BFP pair. The fluorescence signal may originate from a spatially unresolved set of sources that could include some receptors with only BFP as well as those complexes having a distribution of GFP/BFP distances and angles. Therefore the R values should be considered as estimates of the upper limits of the mean separations in the complexes. Furthermore, we cannot exclude the possibility that some or all of the decrease in FRET can be attributed to a change in the orientation of the donor and acceptor fluorophores caused by a change in the orientation but not the average distance between the intracellular domains. Since we cannot measure the orientation of the fluorophores with respect to each other, the calculations and conclusions assumed no change in the orientation of the fluorophores on ligand binding. Nevertheless, a change in the structure of the IFN-{gamma} receptor complex is unequivocally observed by the change in the FRET after addition of IFN-{gamma} to cells. Although this change is assumed to be a result of changes in distance, the change in FRET observed could be due in whole or part to a rotation of receptor chains after interaction with ligand. Back

* This study was supported in part by United States Public Health Services Grants RO1-CA46465 from NCI, National Institutes of Health; RO1-AI36450, RO1-AI43369, and 2T32AI07403 from NIAID, National Institutes of Health (to S. P.); and an award from the Milstein Family Foundation (to S. P.). Back

|| To whom correspondence should be addressed: Dept. of Molecular Genetics, Microbiology, and Immunology, Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, NJ 08854-5635. Tel.: 732-235-4567; Fax: 732-235-5223; E-mail: Pestka{at}umdnj.edu


   REFERENCES
TOP
 ABSTRACT
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Fields, S., and Song, O. (1989) A novel genetic system to detect protein-protein interactions. Nature 340, 245 246[CrossRef][Medline]

  2. Aronheim, A., Zandi, E., Hennemann, H., Elledge, S. J., and Karin, M. (1997) Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol. Cell. Biol. 17, 3094 –3102[Abstract/Free Full Text]

  3. Bartel, P., Chien, C. T., Sternglanz, R., and Fields, S. (1993) Elimination of false positives that arise in using the two-hybrid system. BioTechniques 14, 920 –924[Medline]

  4. Durfee, T., Becherer, K., Chen, P.-L., Yeh, S.-H., Yang, Y., Kilburn, A., Lee, W.-H., and Elledge, S. J. (1993) The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7, 555 –569[Abstract/Free Full Text]

  5. Hardy, C. F., Sussel, L., and Shore, D. (1992) A RAP1-interacting protein involved in transcriptional silencing and telomere length regulation. Genes Dev. 6, 801 –814[Abstract/Free Full Text]

  6. Luban, J., Bossolt, K. L., Franke, E. K., Kalpana, G. V., and Goff, S. P. (1993) Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73, 1067 –1078[CrossRef][Medline]

  7. Vojtek, A. B., Hollenberg, S. M., and Cooper, J. A. (1993) Mammalian ras interacts directly with the serine/threonine kinase raf. Cell 74, 205 –214[CrossRef][Medline]

  8. Yang, X., Hubbard, E. J. A., and Carlson, M. (1992) A protein kinase substrate identified by the two-hybrid system. Science 257, 680 –682[Abstract/Free Full Text]

  9. Pollack, B. P., Kotenko, S. V., He, W., Izotova, L. S., Barnoski, B. L., and Pestka, S. (1999) The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J. Biol. Chem. 274, 31531 –31542[Abstract/Free Full Text]

  10. Sarkar, S., Pollack, B. P., Lin, K. T., Kotenko, S. V., Cook, J. R., Lewis, A., and Pestka, S. (2001) hTid-1, a human DnaJ protein, modulates the interferon signaling pathway. J. Biol. Chem. 276, 49034 –49042[Abstract/Free Full Text]

  11. Cantor, C. R., and Schimmel, P. R. (1980) Biophysical Chemistry Part II: Techniques for the Study of Biological Structure and Function, W. H. Freeman & Company, New York

  12. van der Meer, B. W., Coker, G., and Simon, S.-Y. (1994) Resonance Energy Transfer: Theory and Data, Wiley, John & Sons, Incorporated, New York

  13. Langlois, R., Lee, C. C., Cantor, C. R., Vince, R., and Pestka, S. (1976) The distance between two functionally significant regions of the 50S Escherichia coli ribosome: the erythromycin binding site and proteins L7/L12. J. Mol. Biol. 106, 297 –313[CrossRef][Medline]

  14. Pestka, S., Kotenko, S. V., Muthukumaran, G., Izotova, L. S., Cook, J. R., and Garotta, G. (1997) The interferon {gamma} (IFN-{gamma}) receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev. 8, 189 –206[CrossRef][Medline]

  15. Broudy, V. C., Lin, N. L., Buhring, H. J., Komatsu, N., and Kavanagh, T. J. (1998) Analysis of c-kit receptor dimerization by fluorescence resonance energy transfer. Blood 91, 898 –906[Abstract/Free Full Text]

  16. Damjanovich, S., Bene, L., Matko, J., Alileche, A., Goldman, C. K., Sharrow, S., and Waldmann, T. A. (1997) Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: a fluorescence resonance energy transfer study. Proc. Natl. Acad. Sci. U. S. A. 94, 13134 –13139[Abstract/Free Full Text]

  17. Guo, C., Dower, S. K., Holowka, D., and Baird, B. (1995) Fluorescence resonance energy transfer reveals interleukin (IL)-1-dependent aggregation of IL-1 type I receptors that correlates with receptor activation. J. Biol. Chem. 270, 27562 –27568[Abstract/Free Full Text]

  18. Kenworthy, A. K., and Edidin, M. (1998) Distribution of a glycosylphosphatidylinositol-anchored protein at the apical surface of MDCK cells examined at a resolution of <100 Å using imaging fluorescence resonance energy transfer. J. Cell Biol. 142, 69 –84[Abstract/Free Full Text]

  19. Heim, R., Prasher, D. C., and Tsien, R. Y. (1994) Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc. Natl. Acad. Sci. U. S. A. 91, 12501 –12504[Abstract/Free Full Text]

  20. Prasher, D. C. (1995) Using GFP to see the light. Trends Genet. 11, 320 –323[CrossRef][Medline]

  21. Day, R. N. (1998) Visualization of Pit-1 transcription factor interactions in the living cell nucleus by fluorescence resonance energy transfer microscopy. Mol. Endocrinol. 12, 1410 –1419[Abstract/Free Full Text]

  22. Gordon, G. W., Berry, G., Liang, X. H., Levine, B., and Herman, B. (1998) Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy. Biophys. J. 74, 2702 –2713[Medline]

  23. Janetopoulos, C., Jin, T., and Devreotes, P. (2001) Receptor-mediated activation of heterotrimeric G-proteins in living cells. Science 291, 2408 –2411[Abstract/Free Full Text]

  24. Li, H. Y., Ng, E. K., Lee, S. M., Kotaka, M., Tsui, S. K., Lee, C. Y., Fung, K. P., and Waye, M. M. (2001) Protein-protein interaction of FHL3 with FHL2 and visualization of their interaction by green fluorescent proteins (GFP) two-fusion fluorescence resonance energy transfer (FRET). J. Cell. Biochem. 80, 293 –303[CrossRef][Medline]

  25. Llopis, J., Westin, S., Ricote, M., Wang, Z., Cho, C. Y., Kurokawa, R., Mullen, T. M., Rose, D. W., Rosenfeld, M. G., Tsien, R. Y., Glass, C. K., and Wang, J. (2000) Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription. Proc. Natl. Acad. Sci. U. S. A. 97, 4363 –4368[Abstract/Free Full Text]

  26. Mahajan, N. P., Linder, K., Berry, G., Gordon, G. W., Heim, R., and Herman, B. (1998) Bcl-2 and Bax interactions in mitochondria probed with green fluorescent protein and fluorescence resonance energy transfer. Nat. Biotechnol. 16, 547 –552[CrossRef][Medline]

  27. Margolin, W. (2000) Green fluorescent protein as a reporter for macromolecular localization in bacterial cells. Methods 20, 62 –72[CrossRef][Medline]

  28. Mizuno, H., Sawano, A., Eli, P., Hama, H., and Miyawaki, A. (2001) Red fluorescent protein from Discosoma as a fusion tag and a partner for fluorescence resonance energy transfer. Biochemistry 40, 2502 –2510[CrossRef][Medline]

  29. Overton, M. C., and Blumer, K. J. (2000) G-protein-coupled receptors function as oligomers in vivo. Curr. Biol. 10, 341 –344[CrossRef][Medline]

  30. Pollok, B. A., and Heim, R. (1999) Using GFP in FRET-based applications. Trends Cell Biol. 9, 57 –60[CrossRef][Medline]

  31. Prufer, K., Racz, A., Lin, G. C., and Barsony, J. (2000) Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors. J. Biol. Chem. 275, 41114 –41123[Abstract/Free Full Text]

  32. Schmid, J. A., Birbach, A., Hofer-Warbinek, R., Pengg, M., Burner, U., Furtmuller, P. G., Binder, B. R., and de Martin, R. (2000) Dynamics of NF{kappa}B and I{kappa}B{alpha} studied with green fluorescent protein (GFP) fusion proteins. Investigation of GFP-p65 binding to DNA by fluorescence resonance energy transfer. J. Biol. Chem. 275, 17035 –17042[Abstract/Free Full Text]

  33. Sorkin, A., McClure, M., Huang, F., and Carter, R. (2000) Interaction of EGF receptor and grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy. Curr. Biol. 10, 1395 –1398[CrossRef][Medline]

  34. Vanderklish, P. W., Krushel, L. A., Holst, B. H., Gally, J. A., Crossin, K. L., and Edelman, G. M. (2000) Marking synaptic activity in dendritic spines with a calpain substrate exhibiting fluorescence resonance energy transfer. Proc. Natl. Acad. Sci. U. S. A. 97, 2253 –2258[Abstract/Free Full Text]

  35. Xia, Z., Zhou, Q., Lin, J., and Liu, Y. (2001) Stable SNARE complex prior to evoked synaptic vesicle fusion revealed by fluorescence resonance energy transfer. J. Biol. Chem. 276, 1766 –1771[Abstract/Free Full Text]

  36. Harpur, A. G., Wouters, F. S., and Bastiaens, P. I. (2001) Imaging FRET between spectrally similar GFP molecules in single cells. Nat. Biotechnol. 19, 167 –169

  37. Mochizuki, N., Yamashita, S., Kurokawa, K., Ohba, Y., Nagai, T., Miyawaki, A., and Matsuda, M. (2001) Spatio-temporal images of growth-factor-induced activation of Ras and Rap1. Nature 411, 1065 –1068[CrossRef][Medline]

  38. Langer, J. A., and Pestka, S. (1988) Interferon receptors. Immunol. Today 9, 393 –400[CrossRef][Medline]

  39. Pestka, S., Langer, J. A., Zoon, K. C., and Samuel, C. E. (1987) Interferons and their actions. Annu. Rev. Biochem. 56, 727 –777[CrossRef][Medline]

  40. Pestka, S. (1997) The interferon receptors. Semin. Oncol. 24, Suppl. 9, S9-18 –S9-40

  41. Mariano, T. M., Kozak, C. A., Langer, J. A., and Pestka, S. (1987) The mouse immune interferon receptor gene is located on chromosome 10. J. Biol. Chem. 262, 5812 –5814[Abstract/Free Full Text]

  42. Rashidbaigi, A., Langer, J. A., Jung, V., Jones, C., Morse, H. G., Tischfield, J. A., Trill, J. J., Kung, H.-F., Pestka, S., and Kung, H. F. (1986) The gene for the human immune interferon receptor is located on chromosome 6. Proc. Natl. Acad. Sci. U. S. A. 83, 384 –388[Abstract/Free Full Text]

  43. Hibino, Y., Mariano, T. M., Kumar, C. S., Kozak, C. A., and Pestka, S. (1991) Expression and reconstitution of a biologically active mouse interferon {gamma} receptor in hamster cells: chromosomal location of an accessory factor. J. Biol. Chem. 266, 6948 –6951[Abstract/Free Full Text]

  44. Jung, V., Rashidbaigi, A., Jones, C., Tischfield, J. A., Shows, T. B., and Pestka, S. (1987) Human chromosomes 6 and 21 are required for sensitivity to human interferon {gamma}. Proc. Natl. Acad. Sci. U. S. A. 84, 4151 –4155[Abstract/Free Full Text]

  45. Jung, V., Jones, C., Rashidbaigi, A., Geyer, D. D., Morse, H. G., Wright, R. B., and Pestka, S. (1988) Chromosome mapping of biological pathways by fluorescence-activated cell sorting and cell fusion: the human interferon {gamma} receptor as a model system. Somat. Cell Mol. Genet. 14, 583 –592[CrossRef][Medline]

  46. Youssoufian, H., Longmore, G., Neumann, D., Yoshimura, A., and Lodish, H. F. (1993) Structure, function, and activation of the erythropoietin receptor. Blood 81, 2223 –2236[Free Full Text]

  47. Lemmon, M. A., Bu, Z., Ladbury, J. E., Zhou, M., Pinchasi, D., Lax, I., Engelman, D. M., and Schlessinger, J. (1997) Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J. 16, 281 –294[CrossRef][Medline]

  48. Watowich, S. S., Yoshimura, A., Longmore, G. D., Hilton, D. J., Yoshimura, Y., and Lodish, H. F. (1992) Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl. Acad. Sci. U. S. A. 89, 2140 –2144[Abstract/Free Full Text]

  49. Watowich, S. S., Hilton, D. J., and Lodish, H. F. (1994) Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol. Cell. Biol. 14, 3535 –3549[Abstract/Free Full Text]

  50. Yarden, Y., and Schlessinger, J. (1987) Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 26, 1434 –1442[CrossRef][Medline]

  51. Yarden, Y., and Schlessinger, J. (1987) Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26, 1443 –1451[CrossRef][Medline]

  52. Zhou, M., Felder, S., Rubinstein, M., Hurwitz, D. R., Ullrich, A., Lax, I., and Schlessinger, J. (1993) Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation. Biochemistry 32, 8193 –8198[CrossRef][Medline]

  53. Weiss, A., and Schlessinger, J. (1998) Switching signals on or off by receptor dimerization. Cell 94, 277 –280[CrossRef][Medline]

  54. Baer, K., Al Hasani, H., Parvaresch, S., Corona, T., Rufer, A., Nolle, V., Bergschneider, E., and Klein, H. W. (2001) Dimerization-induced activation of soluble insulin/IGF-1 receptor kinases: an alternative mechanism of activation. Biochemistry 40, 14268 –14278[CrossRef][Medline]

  55. Bishayee, S., Majumdar, S., Khire, J., and Das, M. (1989) Ligand-induced dimerization of the platelet-derived growth factor receptor. Monomer-dimer interconversion occurs independent of receptor phosphorylation. J. Biol. Chem. 264, 11699 –11705[Abstract/Free Full Text]

  56. Bouvier, M. (2001) Oligomerization of G-protein-coupled transmitter receptors. Nat. Rev. Neurosci. 2, 274 –286[CrossRef][Medline]

  57. Brennan, P. J., Kumagai, T., Berezov, A., Murali, R., Greene, M. I., and Kumogai, T. (2000) HER2/neu: mechanisms of dimerization/oligomerization. Oncogene 19, 6093 –6101[CrossRef][Medline]

  58. Chan, F. K., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L., and Lenardo, M. J. (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351 –2354[Abstract/Free Full Text]

  59. Chow, D., Ho, J., Nguyen Pham, T. L., Rose-John, S., and Garcia, K. C. (2001) In vitro reconstitution of recognition and activation complexes between interleukin-6 and gp130. Biochemistry 40, 7593 –7603[Medline]

  60. Devi, L. A. (2001) Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol. Sci. 22, 532 –537[CrossRef][Medline]

  61. Gadella, T. W., Jr., and Jovin, T. M. (1995) Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation. J. Cell Biol. 129, 1543 –1558[Abstract/Free Full Text]

  62. Gamett, D. C., Pearson, G., Cerione, R. A., and Friedberg, I. (1997) Secondary dimerization between members of the epidermal growth factor receptor family. J. Biol. Chem. 272, 12052 –12056[Abstract/Free Full Text]

  63. Raffioni, S., Zhu, Y. Z., Bradshaw, R. A., and Thompson, L. M. (1998) Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation. J. Biol. Chem. 273, 35250 –35259[Abstract/Free Full Text]

  64. Guimond, A., Sulea, T., Zwaagstra, J. C., Ekiel, I., and O’Connor-McCourt, M. D. (2002) Identification of a functional site on the type I TGF-ß receptor by mutational analysis of its ectodomain. FEBS Lett. 513, 147 –152[CrossRef][Medline]

  65. Jiang, G., and Hunter, T. (1999) Receptor signaling: when dimerization is not enough. Curr. Biol. 9, R568 –R571[CrossRef][Medline]

  66. Johannessen, L. E., Haugen, K. E., Ostvold, A. C., Stang, E., and Madshus, I. H. (2001) Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms. Biochem. J. 356, 87 –96[CrossRef][Medline]

  67. Kan, M., Wu, X., Wang, F., and McKeehan, W. L. (1999) Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase. J. Biol. Chem. 274, 15947 –15952[Abstract/Free Full Text]

  68. Maher, D. W., Strawn, L. M., and Donoghue, D. J. (1993) Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation. Oncogene 8, 533 –541[Medline]

  69. Martin-Fernandez, M., Clarke, D. T., Tobin, M. J., Jones, S. V., and Jones, G. R. (2002) Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling. Biophys. J. 82, 2415 –2427[Medline]

  70. McInnes, C., and Sykes, B. D. (1997) Growth factor receptors: structure, mechanism, and drug discovery. Biopolymers 43, 339 –366[CrossRef][Medline]

  71. Moriki, T., Maruyama, H., and Maruyama, I. N. (2001) Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J. Mol. Biol. 311, 1011 –1026[CrossRef][Medline]

  72. Morrow, M. R., and Grant, C. W. (2000) The EGF receptor transmembrane domain: peptide-peptide interactions in fluid bilayer membranes. Biophys. J. 79, 2024 –2032[Medline]

  73. Sako, Y., Minoghchi, S., and Yanagida, T. (2000) Single-molecule imaging of EGFR signalling on the surface of living cells. Nat. Cell Biol. 2, 168 –172[CrossRef][Medline]

  74. Siegel, R. M., Frederiksen, J. K., Zacharias, D. A., Chan, F. K., Johnson, M., Lynch, D., Tsien, R. Y., and Lenardo, M. J. (2000) Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288, 2354 –2357[Abstract/Free Full Text]

  75. van den Akker, F. (2001) Structural insights into the ligand binding domains of membrane bound guanylyl cyclases and natriuretic peptide receptors. J. Mol. Biol. 311, 923 –937[CrossRef][Medline]

  76. Wang, F., Kan, M., McKeehan, K., Jang, J. H., Feng, S., and McKeehan, W. L. (1997) A homeo-interaction sequence in the ectodomain of the fibroblast growth factor receptor. J. Biol. Chem. 272, 23887 –23895[Abstract/Free Full Text]

  77. Watowich, S. S. (1999) Activation of erythropoietin signaling by receptor dimerization. Int. J. Biochem. Cell Biol. 31, 1075 –1088[CrossRef][Medline]

  78. Wiesmann, C., Muller, Y. A., and de Vos, A. M. (2000) Ligand-binding sites in Ig-like domains of receptor tyrosine kinases. J. Mol. Med. 78, 247 –260[CrossRef][Medline]

  79. Wilson, I. A., and Jolliffe, L. K. (1999) The structure, organization, activation and plasticity of the erythropoietin receptor. Curr. Opin. Struct. Biol. 9, 696 –704[CrossRef][Medline]

  80. Wiseman, P. W., and Petersen, N. O. (1999) Image correlation spectroscopy. II. Optimization for ultrasensitive detection of preexisting platelet-derived growth factor-beta receptor oligomers on intact cells. Biophys. J. 76, 963 –977[Medline]

  81. Aguet, M., Dembic, Z., and Merlin, G. (1988) Molecular cloning and expression of the human interferon-{gamma} receptor. Cell 55, 273 –280[CrossRef][Medline]

  82. Soh, J., Donnelly, R. J., Kotenko, S., Mariano, T. M., Cook, J. R., Wang, N., Emanuel, S. L., Schwartz, B., Miki, T., and Pestka, S. (1994) Identification and sequence of an accessory factor required for activation of the human interferon {gamma} receptor. Cell 76, 793 –802[CrossRef][Medline]

  83. Darnell, J. E., Jr., Kerr, I. M., and Stark, G. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415 –1421[Abstract/Free Full Text]

  84. Bach, E. A., Tanner, J. W., Marsters, S., Ashkenazi, A., Aguet, M., Shaw, A. S., and Schreiber, R. D. (1996) Ligand-induced assembly and activation of the {gamma} interferon receptor in intact cells. Mol. Cell. Biol. 16, 3214 –3221[Abstract/Free Full Text]

  85. Ishiharu, C., Ochiai, K., Kagami, M., Matsuyama, G., Koya, N., and Tomioka, H. (1998) Interferon-{gamma} receptor ß-chain expression and formation of {alpha}- and ß-chain complexes after receptor conjugation on human peripheral eosinophils. Int. Arch. Allergy Immunol. 117, Suppl. 1, 72 –76

  86. Kotenko, S. V., Izotova, L. S., Pollack, B. P., Mariano, T. M., Donnelly, R. J., Muthukumaran, G., Cook, J. R., Garotta, G., Silvennoinen, O., Ihle, J. N., and Pestka, S. (1995) Interaction between the components of the interferon {gamma} receptor complex. J. Biol. Chem. 270, 20915 –20921[Abstract/Free Full Text]

  87. Kotenko, S. V., Izotova, L. S., Pollack, B. P., Muthukumaran, G., Paukku, K., Silvennoinen, O., Ihle, J. N., and Pestka, S. (1996) Other kinases can substitute for jak2 in signal transduction by IFN-{gamma}. J. Biol. Chem. 271, 17174 –17182[Abstract/Free Full Text]

  88. Kotenko, S. V., Krause, C. D., Izotova, L. S., Pollack, B. P., Wu, W., and Pestka, S. (1997) Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J. 16, 5894 –5903[CrossRef][Medline]

  89. Heim, R., Cubitt, A. B., and Tsien, R. Y. (1995) Improved green fluorescence. Nature 373, 663 –664[Medline]

  90. Heim, R., and Tsien, R. Y. (1996) Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr. Biol. 6, 178 –182[CrossRef][Medline]

  91. Jung, V., Jones, C., Kumar, C. S., Stefanos, S., O’Connell, S., and Pestka, S. (1990) Expression and reconstitution of a biologically active human interferon {gamma} receptor in hamster cells. J. Biol. Chem. 265, 1827 –1830[Abstract/Free Full Text]

  92. Ormo, M., Cubitt, A. B., Kallio, K., Gross, L. A., Tsien, R. Y., and Remington, S. J. (1996) Crystal structure of the Aequorea victoria green fluorescent protein. Science 273, 1392 –1395[Abstract]

  93. Hemmi, S., Bohni, R., Stark, G., Di Marco, F., and Aguet, M. (1994) A novel member of the interferon receptor family complements functionality of the murine interferon {gamma} receptor in human cells. Cell 76, 803 –810[CrossRef][Medline]

  94. Lembo, D., Ricciardi-Castagnoli, P., Alber, G., Ozmen, L., Landolfo, S., Bluthmann, H., Dembic, Z., Kotenko, S. V., Cook, J. R., Pestka, S., and Garotta, G. (1996) Mouse macrophages carrying both subunits of the human interferon-{gamma} (IFN-{gamma}) receptor respond to human IFN-{gamma} but do not acquire full protection against viral cytopathic effect. J. Biol. Chem. 271, 32659 –32666[Abstract/Free Full Text]

  95. Pestka, S. (2000) The human interferon {alpha} species and receptors. Biopolymers 55, 254 –287[CrossRef][Medline]

  96. Fountoulakis, M., Juranville, J.-F., Maris, A., Ozmen, L., and Garotta, G. (1990) One interferon {gamma} receptor binds one interferon {gamma} dimer. J. Biol. Chem. 265, 19758 –19767[Abstract/Free Full Text]

  97. Fountoulakis, M., Juranville, J.-F., Stuber, D., Weibel, E. K., and Garotta, G. (1990) Purification and biochemical characterization of a soluble human interferon {gamma} receptor expressed in Escherichia coli. J. Biol. Chem. 265, 13268 –13275[Abstract/Free Full Text]

  98. Fountoulakis, M., Zulauf, M., Lusting, A., and Garotta, G. (1992) Stoichiometry of interaction between interferon {gamma} and its receptor. Eur. J. Biochem. 208, 781 –787[Medline]

  99. Greenlund, A. C., Schreiber, R. D., Goeddel, D. V., and Pennica, D. (1993) Interferon-{gamma} induces receptor dimerization in solution and on cells. J. Biol. Chem. 268, 18103 –18110[Abstract/Free Full Text]

  100. Krause, C. D., Lunn, C. A., Izotova, L. S., Mirochnitchenko, O., Kotenko, S. V., Lundell, D. J., Narula, S. K., and Pestka, S. (2000) Signaling by covalent heterodimers of interferon-{gamma}. Evidence for one-sided signaling in the active tetrameric receptor complex. J. Biol. Chem. 275, 22995 –23004[Abstract/Free Full Text]

  101. Sakatsume, M., Igarashi, K., Winestock, K. D., Garotta, G., Larner, A. C., and Finbloom, D. S. (1995) The Jak kinases differentially associate with the {alpha} and ß (accessory factor) chains of the interferon {gamma} receptor to form a functional receptor unit capable of activating STAT transcription factors. J. Biol. Chem. 270, 17528 –17534[Abstract/Free Full Text]

  102. Cook, J. R., Emanuel, S. L., Donnelly, R. J., Soh, J., Mariano, T. M., Schwartz, B., Rhee, S., and Pestka, S. (1994) Sublocalization of the human interferon-{gamma} receptor accessory factor gene and characterization of accessory factor activity by yeast artificial chromosomal fragmentation. J. Biol. Chem. 269, 7013 –7018[Abstract/Free Full Text]

  103. Soh, J., Donnelly, R. J., Mariano, T. M., Cook, J. R., Schwartz, B., and Pestka, S. (1993) Identification of a yeast artificial chromosome clone encoding an accessory factor for the human interferon {gamma} receptor: evidence for multiple accessory factors. Proc. Natl. Acad. Sci. U. S. A. 90, 8737 –8741[Abstract/Free Full Text]

  104. Barbosa, J. A., Kamarck, M. E., Biro, P. A., Weissman, S. M., and Ruddle, F. H. (1982) Identification of human genomic clones coding the major histocompatibility antigens HLA-a2 and HLA-B7 by DNA-mediated gene transfer. Proc. Natl. Acad. Sci. U. S. A. 79, 6327 –6331[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J. Claudinon, P. Gonnord, E. Beslard, M. Marchetti, K. Mitchell, C. Boularan, L. Johannes, P. Eid, and C. Lamaze
Palmitoylation of Interferon-{alpha} (IFN-{alpha}) Receptor Subunit IFNAR1 Is Required for the Activation of Stat1 and Stat2 by IFN-{alpha}
J. Biol. Chem., September 4, 2009; 284(36): 24328 - 24340.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
K. S. Sinsimer, F. M. Gratacos, A. M. Knapinska, J. Lu, C. D. Krause, A. V. Wierzbowski, L. R. Maher, S. Scrudato, Y. M. Rivera, S. Gupta, et al.
Chaperone Hsp27, a Novel Subunit of AUF1 Protein Complexes, Functions in AU-Rich Element-Mediated mRNA Decay
Mol. Cell. Biol., September 1, 2008; 28(17): 5223 - 5237.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Zaks-Zilberman, A. E. Harrington, T. Ishino, and I. M. Chaiken
Interleukin-5 Receptor Subunit Oligomerization and Rearrangement Revealed by Fluorescence Resonance Energy Transfer Imaging
J. Biol. Chem., May 9, 2008; 283(19): 13398 - 13406.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Pestka
The Interferons: 50 Years after Their Discovery, There Is Much More to Learn
J. Biol. Chem., July 13, 2007; 282(28): 20047 - 20051.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. S. Garcia, R. E. Curiel, J. M. Mwatibo, S. Pestka, H. Li, and I. Espinoza-Delgado
The Antineoplastic Agent Bryostatin-1 Differentially Regulates IFN-{gamma} Receptor Subunits in Monocytic Cells: Transcriptional and Posttranscriptional Control of IFN-{gamma}R2
J. Immunol., August 15, 2006; 177(4): 2707 - 2716.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
C. Stuhlmann-Laeisz, S. Lang, A. Chalaris, P. Krzysztof, S. Enge, J. Eichler, U. Klingmuller, M. Samuel, M. Ernst, S. Rose-John, et al.
Forced Dimerization of gp130 Leads to Constitutive STAT3 Activation, Cytokine-independent Growth, and Blockade of Differentiation of Embryonic Stem Cells
Mol. Biol. Cell, July 1, 2006; 17(7): 2986 - 2995.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. M. Kramer, L. Yi, F. Shen, A. Maitra, X. Jiao, T. Jin, and S. L. Gaffen
Cutting Edge: Evidence for Ligand-Independent Multimerization of the IL-17 Receptor
J. Immunol., January 15, 2006; 176(2): 711 - 715.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Zabeau, D. Defeau, H. Iserentant, J. Vandekerckhove, F. Peelman, and J. Tavernier
Leptin Receptor Activation Depends on Critical Cysteine Residues in Its Fibronectin Type III Subdomains
J. Biol. Chem., June 17, 2005; 280(24): 22632 - 22640.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. Schroder, K. M. Kroeger, H.-D. Volk, K. A. Eidne, and G. Grutz
Preassociation of nonactivated STAT3 molecules demonstrated in living cells using bioluminescence resonance energy transfer: a new model of STAT activation?
J. Leukoc. Biol., May 1, 2004; 75(5): 792 - 797.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
D. M. Buk, M. Waibel, C. Braig, A. S. Martens, P. C. Heinrich, and L. Graeve
Polarity and lipid raft association of the components of the ciliary neurotrophic factor receptor complex in Madin-Darby canine kidney cells
J. Cell Sci., April 15, 2004; 117(10): 2063 - 2075.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. Schroder, P. J. Hertzog, T. Ravasi, and D. A. Hume
Interferon-{gamma}: an overview of signals, mechanisms and functions
J. Leukoc. Biol., February 1, 2004; 75(2): 163 - 189.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. He, X. Wang, J. Jiang, R. Guan, K. E. Bernstein, P. P. Sayeski, and S. J. Frank
Janus Kinase 2 Determinants for Growth Hormone Receptor Association, Surface Assembly, and Signaling
Mol. Endocrinol., November 1, 2003; 17(11): 2211 - 2227.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Braunstein, S. Brutsaert, R. Olson, and C. Schindler
STATs Dimerize in the Absence of Phosphorylation
J. Biol. Chem., September 5, 2003; 278(36): 34133 - 34140.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M200065-MCP200v1
1/10/805    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krause, C. D.
Right arrow Articles by Pestka, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krause, C. D.
Right arrow Articles by Pestka, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Advertisement
spacer
Advertisement
Advertisement